Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study

Abstract Objective This study aimed to investigate the prevalence of common cardiovascular diseases (CVDs) and their clinical risk factors among patients with cancer and to offer clinical evidence to help manage CVD within this population. Methods Patients with cancer who were aged ≥ 20 years were s...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng Jiang, Yun-Xiang Chen, Qing-Shan Geng, An-Bang Liu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-025-04976-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238013473718272
author Cheng Jiang
Yun-Xiang Chen
Qing-Shan Geng
An-Bang Liu
author_facet Cheng Jiang
Yun-Xiang Chen
Qing-Shan Geng
An-Bang Liu
author_sort Cheng Jiang
collection DOAJ
description Abstract Objective This study aimed to investigate the prevalence of common cardiovascular diseases (CVDs) and their clinical risk factors among patients with cancer and to offer clinical evidence to help manage CVD within this population. Methods Patients with cancer who were aged ≥ 20 years were selected from the National Health and Nutrition Examination Survey (NHANES) 2015–2020. The prevalence of CVD and its components was analyzed using weighted analysis to obtain standardized prevalence. Subgroup analyses for gender and age were also performed. Lastly, the clinical risk factors for CVD in patients with cancer were identified by conducting multivariable logistic regression. Results A total of 1729 individuals diagnosed with cancer were included, among which 432 had CVD. Weighted analysis further revealed that 21.21% (95%CI: 17.55–24.86) of the patients with cancer had CVD. Moreover, CVD prevalence was 25.12% in males and 18.30% in females (P = 0.01), while it was 26.93% in the age group of ≥ 65 years and 14.58% in the < 65 years age group (P < 0.001). In terms of CVD components, angina pectoris was diagnosed in 4.51% of the patients, myocardial infarction in 8.56%, coronary heart disease in 10.09%, heart failure in 5.08%, and stroke in 7.57%. Multivariable logistic regression analysis indicated that older age (OR = 1.02, 95% CI: 1.01–1.03), smoking history (OR = 1.56, 95% CI: 1.02–2.39 for former smoking and OR = 2.82, 95% CI: 1.59–5.01 for current smoking), hypertension (OR = 2.78, 95% CI: 1.81–4.28), diabetes (OR = 2.04, 95% CI: 1.47–2.84), chronic kidney disease (CKD, OR = 1.73, 95% CI: 1.28–2.34), and antineoplastic or other treatments (OR = 4.83, 95% CI: 2.15–10.85) were statistically significant independent risk factors for CVD in patients with cancer. Conclusions Patients with cancer have a weighted CVD prevalence of 21.21%, with male patients and those ≥ 65 years demonstrating a higher prevalence of CVD. Independent clinical risk factors for CVD in patients with cancer comprise age, smoking history, hypertension, diabetes, CKD, and antineoplastic or other treatments.
format Article
id doaj-art-b19c986e1bfa4400a22f0efaaa115a3d
institution Kabale University
issn 1471-2261
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj-art-b19c986e1bfa4400a22f0efaaa115a3d2025-08-20T04:01:47ZengBMCBMC Cardiovascular Disorders1471-22612025-07-0125111010.1186/s12872-025-04976-2Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional studyCheng Jiang0Yun-Xiang Chen1Qing-Shan Geng2An-Bang Liu3Department of Geriatrics, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s HospitalSchool of Clinical Medicine, Shandong Second Medical UniversityDepartment of Geriatrics, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s HospitalCentral Hospital Affiliated to Shandong First Medical UniversityAbstract Objective This study aimed to investigate the prevalence of common cardiovascular diseases (CVDs) and their clinical risk factors among patients with cancer and to offer clinical evidence to help manage CVD within this population. Methods Patients with cancer who were aged ≥ 20 years were selected from the National Health and Nutrition Examination Survey (NHANES) 2015–2020. The prevalence of CVD and its components was analyzed using weighted analysis to obtain standardized prevalence. Subgroup analyses for gender and age were also performed. Lastly, the clinical risk factors for CVD in patients with cancer were identified by conducting multivariable logistic regression. Results A total of 1729 individuals diagnosed with cancer were included, among which 432 had CVD. Weighted analysis further revealed that 21.21% (95%CI: 17.55–24.86) of the patients with cancer had CVD. Moreover, CVD prevalence was 25.12% in males and 18.30% in females (P = 0.01), while it was 26.93% in the age group of ≥ 65 years and 14.58% in the < 65 years age group (P < 0.001). In terms of CVD components, angina pectoris was diagnosed in 4.51% of the patients, myocardial infarction in 8.56%, coronary heart disease in 10.09%, heart failure in 5.08%, and stroke in 7.57%. Multivariable logistic regression analysis indicated that older age (OR = 1.02, 95% CI: 1.01–1.03), smoking history (OR = 1.56, 95% CI: 1.02–2.39 for former smoking and OR = 2.82, 95% CI: 1.59–5.01 for current smoking), hypertension (OR = 2.78, 95% CI: 1.81–4.28), diabetes (OR = 2.04, 95% CI: 1.47–2.84), chronic kidney disease (CKD, OR = 1.73, 95% CI: 1.28–2.34), and antineoplastic or other treatments (OR = 4.83, 95% CI: 2.15–10.85) were statistically significant independent risk factors for CVD in patients with cancer. Conclusions Patients with cancer have a weighted CVD prevalence of 21.21%, with male patients and those ≥ 65 years demonstrating a higher prevalence of CVD. Independent clinical risk factors for CVD in patients with cancer comprise age, smoking history, hypertension, diabetes, CKD, and antineoplastic or other treatments.https://doi.org/10.1186/s12872-025-04976-2CancerCardiovascular diseasePrevalenceRisk factorsCardio-oncology
spellingShingle Cheng Jiang
Yun-Xiang Chen
Qing-Shan Geng
An-Bang Liu
Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study
BMC Cardiovascular Disorders
Cancer
Cardiovascular disease
Prevalence
Risk factors
Cardio-oncology
title Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study
title_full Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study
title_fullStr Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study
title_full_unstemmed Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study
title_short Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study
title_sort prevalence and clinical risk factors of cardiovascular disease in patients with cancer a cross sectional study
topic Cancer
Cardiovascular disease
Prevalence
Risk factors
Cardio-oncology
url https://doi.org/10.1186/s12872-025-04976-2
work_keys_str_mv AT chengjiang prevalenceandclinicalriskfactorsofcardiovasculardiseaseinpatientswithcanceracrosssectionalstudy
AT yunxiangchen prevalenceandclinicalriskfactorsofcardiovasculardiseaseinpatientswithcanceracrosssectionalstudy
AT qingshangeng prevalenceandclinicalriskfactorsofcardiovasculardiseaseinpatientswithcanceracrosssectionalstudy
AT anbangliu prevalenceandclinicalriskfactorsofcardiovasculardiseaseinpatientswithcanceracrosssectionalstudy